{"id":7626,"date":"2026-06-09T12:12:57","date_gmt":"2026-06-09T16:12:57","guid":{"rendered":"https:\/\/elglobal.do\/?p=7626"},"modified":"2026-06-09T12:13:25","modified_gmt":"2026-06-09T16:13:25","slug":"nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso","status":"publish","type":"post","link":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/","title":{"rendered":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"895\" height=\"504\" src=\"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png\" alt=\"\" class=\"wp-image-7627\" style=\"aspect-ratio:1.775839857298583;width:485px;height:auto\" srcset=\"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png 895w, https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59-300x169.png 300w, https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59-768x432.png 768w\" sizes=\"auto, (max-width: 895px) 100vw, 895px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\"><strong>Madrid.-<\/strong>Un nuevo f\u00e1rmaco oral basado en un receptor de\u00a0<strong>GLP-1<\/strong>, conocido como\u00a0<strong>elecoglipron<\/strong>, ha probado su eficacia en la fase 2B de un ensayo para reducir tanto los niveles de\u00a0<strong>az\u00facar<\/strong>\u00a0en sangre en personas con\u00a0<strong>diabetes tipo 2<\/strong>\u00a0como el\u00a0<strong>peso corporal<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El nuevo medicamento, presentado este lunes en la sesi\u00f3n cient\u00edfica del encuentro de la&nbsp;<strong>Asociaci\u00f3n Americana de Diabetes<\/strong>&nbsp;y recogido por la revista&nbsp;<strong>The Lancet<\/strong>, ha sido desarrollado por la farmac\u00e9utica&nbsp;<strong>AstraZ\u00e9neca<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En estos momentos, la mayor\u00eda de los medicamentos de&nbsp;<strong>GLP-1<\/strong>&nbsp;(<strong>Wegovy<\/strong>&nbsp;o&nbsp;<strong>Mounjaro<\/strong>, entre otros) que hay en el mercado se administran mediante&nbsp;<strong>inyecci\u00f3n subcut\u00e1nea<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La\u00a0<strong>semaglutida<\/strong>\u00a0(el conocido &#8216;Ozempic&#8217;), autorizada para la diabetes tipo 2, puede tomarse en forma de comprimido, pero debe administrarse en\u00a0<strong>ayunas<\/strong>\u00a0a primera hora de la ma\u00f1ana, y hay que evitar la ingesta de alimentos y agua durante los\u00a0<strong>30 minutos<\/strong>\u00a0posteriores.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ensayo internacional&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El ensayo internacional&nbsp;<strong>Solstice<\/strong>, llevado a cabo en&nbsp;<strong>nueve pa\u00edses<\/strong>&nbsp;y liderado por la investigadora del hospital&nbsp;<strong>Mass General Brigham<\/strong>&nbsp;de&nbsp;<strong>Boston<\/strong>,&nbsp;<strong>Vanita Aroda<\/strong>, ha probado una pastilla basada en el&nbsp;<strong>GLP-1<\/strong>&nbsp;<strong>elecoglipron<\/strong>&nbsp;sin esas limitaciones.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En el estudio han participado&nbsp;<strong>406 personas<\/strong>&nbsp;con diabetes tipo 2 que fueron asignadas aleatoriamente a dos grupos de tratamiento. Hubo tres fases que se desarrollaron en&nbsp;<strong>26 semanas<\/strong>: dosis iniciales, aumento de la medicaci\u00f3n y dosis de mantenimiento.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los investigadores observaron que, en todas las concentraciones de dosis, el medicamento redujo los niveles de&nbsp;<strong>glucosa<\/strong>&nbsp;de forma notablemente mayor en el grupo que lo tom\u00f3 respecto al que recibi\u00f3&nbsp;<strong>placebo<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Resultados del estudio<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Hasta el&nbsp;<strong>89.6 %<\/strong>&nbsp;de los participantes que tomaron el medicamento alcanzaron un nivel de&nbsp;<strong>HbA1c<\/strong>&nbsp;(la hemoglobina glicosilada, que mide el nivel promedio de glucosa en el cuerpo durante los \u00faltimos 2-3 meses) del&nbsp;<strong>7 %<\/strong>, que es el objetivo est\u00e1ndar en la mayor\u00eda de los adultos con diabetes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por el contrario, solo el&nbsp;<strong>24.9 %<\/strong>&nbsp;de las personas que recibieron placebo alcanzaron ese nivel saludable.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En cuanto a la&nbsp;<strong>p\u00e9rdida de peso<\/strong>, el&nbsp;<strong>72.3 %<\/strong>&nbsp;de los participantes que recibieron el tratamiento logr\u00f3 una reducci\u00f3n de peso de al menos un&nbsp;<strong>5 %<\/strong>, en comparaci\u00f3n con el&nbsp;<strong>20.2 %<\/strong>&nbsp;del grupo del placebo que tambi\u00e9n consigui\u00f3 perder kilos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La\u00a0<strong>seguridad<\/strong>\u00a0y la\u00a0<strong>tolerabilidad<\/strong>\u00a0fueron similares a las de otros medicamentos de\u00a0<strong>GLP-1<\/strong>, informan los autores.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cHasta la fecha, las terapias con&nbsp;<strong>GLP-1<\/strong>&nbsp;se han limitado a formulaciones inyectables u orales, cada una con sus propias limitaciones en cuanto a la administraci\u00f3n y la dosificaci\u00f3n. Nuestro ensayo allana el camino hacia f\u00e1rmacos orales que superen esas limitaciones en el tratamiento de la diabetes tipo 2\u201d, se\u00f1ala&nbsp;<strong>Aroda<\/strong>, directora de Investigaci\u00f3n en Diabetes en&nbsp;<strong>Mass General Brigham<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aroda es tambi\u00e9n la investigadora principal del estudio&nbsp;<strong>Reimagine 1<\/strong>, un ensayo aleatorizado y controlado que evalu\u00f3&nbsp;<strong>CagriSema<\/strong>, otra terapia que ha logrado que el&nbsp;<strong>87 %<\/strong>&nbsp;de los participantes haya alcanzado el nivel objetivo de&nbsp;<strong>HbA1c<\/strong>&nbsp;del&nbsp;<strong>7 %<\/strong>. Sus resultados han sido publicados en otro art\u00edculo de la revista&nbsp;<strong>The Lancet Diabetes and Endocrinology<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Madrid.-Un nuevo f\u00e1rmaco oral basado en un receptor de\u00a0GLP-1, conocido como\u00a0elecoglipron, ha probado su eficacia en la fase 2B de un ensayo para reducir tanto los niveles de\u00a0az\u00facar\u00a0en sangre en&hellip; <\/p>\n","protected":false},"author":1,"featured_media":7627,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[14,181],"tags":[4290,1615,4289,3526],"class_list":["post-7626","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-slider","category-salud","tag-diabetes","tag-estudio","tag-pastilloglp-1","tag-sobrepeso"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO\" \/>\n<meta property=\"og:description\" content=\"Madrid.-Un nuevo f\u00e1rmaco oral basado en un receptor de\u00a0GLP-1, conocido como\u00a0elecoglipron, ha probado su eficacia en la fase 2B de un ensayo para reducir tanto los niveles de\u00a0az\u00facar\u00a0en sangre en&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/\" \/>\n<meta property=\"og:site_name\" content=\"EL GLOBAL INFORMATIVO\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T16:12:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T16:13:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png\" \/>\n\t<meta property=\"og:image:width\" content=\"895\" \/>\n\t<meta property=\"og:image:height\" content=\"504\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"EL GLOBAL\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"EL GLOBAL\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/\"},\"author\":{\"name\":\"EL GLOBAL\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/#\\\/schema\\\/person\\\/0c97ec2c7714fb605d230c292f64d55f\"},\"headline\":\"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso\",\"datePublished\":\"2026-06-09T16:12:57+00:00\",\"dateModified\":\"2026-06-09T16:13:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/\"},\"wordCount\":568,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/image-59.png\",\"keywords\":[\"#Diabetes\",\"#estudio\",\"#PastilloGLP-1\",\"#Sobrepeso\"],\"articleSection\":[\"NOTICIAS RELEVANTES\",\"SALUD\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/\",\"url\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/\",\"name\":\"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/image-59.png\",\"datePublished\":\"2026-06-09T16:12:57+00:00\",\"dateModified\":\"2026-06-09T16:13:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/image-59.png\",\"contentUrl\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/image-59.png\",\"width\":895,\"height\":504},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/2026\\\/06\\\/09\\\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/elglobal.do\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/#website\",\"url\":\"https:\\\/\\\/elglobal.do\\\/\",\"name\":\"EL GLOBAL INFORMATIVO\",\"description\":\"Peri\u00f3dico digital de la Rep\u00fablica Dominicana que ofrece noticias, novedades, pol\u00edtica y las \u00faltimas actualidades, con informaci\u00f3n veraz y oportuna para mantenerte siempre informad\",\"publisher\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elglobal.do\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/#organization\",\"name\":\"EL GLOBAL.DO INFORMATIVO\",\"url\":\"https:\\\/\\\/elglobal.do\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/icon.png\",\"contentUrl\":\"https:\\\/\\\/elglobal.do\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/icon.png\",\"width\":512,\"height\":512,\"caption\":\"EL GLOBAL.DO INFORMATIVO\"},\"image\":{\"@id\":\"https:\\\/\\\/elglobal.do\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/elglobal.do\\\/#\\\/schema\\\/person\\\/0c97ec2c7714fb605d230c292f64d55f\",\"name\":\"EL GLOBAL\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g\",\"caption\":\"EL GLOBAL\"},\"description\":\"El Global Informativo es un peri\u00f3dico digital de Rep\u00fablica Dominicana que se dedica a cubrir temas importantes, como la pol\u00edtica local, geopol\u00edtica, econom\u00eda, tecnolog\u00eda, noticias internacionales y eventos relacionados con la gesti\u00f3n social, cultural y humana. Su objetivo principal es mantener a la poblaci\u00f3n informada, ofreciendo una visi\u00f3n amplia y actualizada de lo que sucede tanto en el pa\u00eds como en el mundo. Est\u00e1 dirigido por un grupo de periodistas experimentados, lo que garantiza la calidad y la precisi\u00f3n de la informaci\u00f3n que ofrecen. Tiene su sede en la ciudad de Santo Domingo y es parte integral del portafolio de la empresa, MC Global S.R.L.\",\"sameAs\":[\"https:\\\/\\\/elglobal.do\",\"https:\\\/\\\/www.instagram.com\\\/elglobal.do_informativo\\\/\"],\"url\":\"https:\\\/\\\/elglobal.do\\\/index.php\\\/author\\\/elglobaluserpro\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/","og_locale":"es_ES","og_type":"article","og_title":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO","og_description":"Madrid.-Un nuevo f\u00e1rmaco oral basado en un receptor de\u00a0GLP-1, conocido como\u00a0elecoglipron, ha probado su eficacia en la fase 2B de un ensayo para reducir tanto los niveles de\u00a0az\u00facar\u00a0en sangre en&hellip;","og_url":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/","og_site_name":"EL GLOBAL INFORMATIVO","article_published_time":"2026-06-09T16:12:57+00:00","article_modified_time":"2026-06-09T16:13:25+00:00","og_image":[{"width":895,"height":504,"url":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","type":"image\/png"}],"author":"EL GLOBAL","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"EL GLOBAL","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#article","isPartOf":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/"},"author":{"name":"EL GLOBAL","@id":"https:\/\/elglobal.do\/#\/schema\/person\/0c97ec2c7714fb605d230c292f64d55f"},"headline":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso","datePublished":"2026-06-09T16:12:57+00:00","dateModified":"2026-06-09T16:13:25+00:00","mainEntityOfPage":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/"},"wordCount":568,"commentCount":0,"publisher":{"@id":"https:\/\/elglobal.do\/#organization"},"image":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#primaryimage"},"thumbnailUrl":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","keywords":["#Diabetes","#estudio","#PastilloGLP-1","#Sobrepeso"],"articleSection":["NOTICIAS RELEVANTES","SALUD"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/","url":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/","name":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso - EL GLOBAL INFORMATIVO","isPartOf":{"@id":"https:\/\/elglobal.do\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#primaryimage"},"image":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#primaryimage"},"thumbnailUrl":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","datePublished":"2026-06-09T16:12:57+00:00","dateModified":"2026-06-09T16:13:25+00:00","breadcrumb":{"@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#primaryimage","url":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","contentUrl":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","width":895,"height":504},{"@type":"BreadcrumbList","@id":"https:\/\/elglobal.do\/index.php\/2026\/06\/09\/nueva-pastilla-de-glp-1-demuestra-su-eficacia-frente-a-la-diabetes-y-el-sobrepeso\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/elglobal.do\/"},{"@type":"ListItem","position":2,"name":"Nueva pastilla de GLP-1 demuestra su eficacia frente a la diabetes y el sobrepeso"}]},{"@type":"WebSite","@id":"https:\/\/elglobal.do\/#website","url":"https:\/\/elglobal.do\/","name":"EL GLOBAL INFORMATIVO","description":"Peri\u00f3dico digital de la Rep\u00fablica Dominicana que ofrece noticias, novedades, pol\u00edtica y las \u00faltimas actualidades, con informaci\u00f3n veraz y oportuna para mantenerte siempre informad","publisher":{"@id":"https:\/\/elglobal.do\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elglobal.do\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/elglobal.do\/#organization","name":"EL GLOBAL.DO INFORMATIVO","url":"https:\/\/elglobal.do\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/elglobal.do\/#\/schema\/logo\/image\/","url":"https:\/\/elglobal.do\/wp-content\/uploads\/2025\/08\/icon.png","contentUrl":"https:\/\/elglobal.do\/wp-content\/uploads\/2025\/08\/icon.png","width":512,"height":512,"caption":"EL GLOBAL.DO INFORMATIVO"},"image":{"@id":"https:\/\/elglobal.do\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/elglobal.do\/#\/schema\/person\/0c97ec2c7714fb605d230c292f64d55f","name":"EL GLOBAL","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/081cfb6cf99faddc6f4e23a0c11ab98c5cf302925382d1c88dc3ed757ab910a3?s=96&d=mm&r=g","caption":"EL GLOBAL"},"description":"El Global Informativo es un peri\u00f3dico digital de Rep\u00fablica Dominicana que se dedica a cubrir temas importantes, como la pol\u00edtica local, geopol\u00edtica, econom\u00eda, tecnolog\u00eda, noticias internacionales y eventos relacionados con la gesti\u00f3n social, cultural y humana. Su objetivo principal es mantener a la poblaci\u00f3n informada, ofreciendo una visi\u00f3n amplia y actualizada de lo que sucede tanto en el pa\u00eds como en el mundo. Est\u00e1 dirigido por un grupo de periodistas experimentados, lo que garantiza la calidad y la precisi\u00f3n de la informaci\u00f3n que ofrecen. Tiene su sede en la ciudad de Santo Domingo y es parte integral del portafolio de la empresa, MC Global S.R.L.","sameAs":["https:\/\/elglobal.do","https:\/\/www.instagram.com\/elglobal.do_informativo\/"],"url":"https:\/\/elglobal.do\/index.php\/author\/elglobaluserpro\/"}]}},"jetpack_featured_media_url":"https:\/\/elglobal.do\/wp-content\/uploads\/2026\/06\/image-59.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/posts\/7626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/comments?post=7626"}],"version-history":[{"count":2,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/posts\/7626\/revisions"}],"predecessor-version":[{"id":7629,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/posts\/7626\/revisions\/7629"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/media\/7627"}],"wp:attachment":[{"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/media?parent=7626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/categories?post=7626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/elglobal.do\/index.php\/wp-json\/wp\/v2\/tags?post=7626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}